» Articles » PMID: 35626900

Early Diagnosis of Pseudohypoparathyroidism Before the Development of Hypocalcemia in a Young Infant

Overview
Specialty Health Services
Date 2022 May 28
PMID 35626900
Authors
Affiliations
Soon will be listed here.
Abstract

Pseudohypoparathyroidism (PHP) is a rare, heterogeneous disorder characterized by end-organ resistance to parathyroid hormone (PTH). PTH resistance causes elevated PTH levels, hypocalcemia, and hyperphosphatemia. Since hypocalcemia causes life-threatening events, early diagnosis is crucial. However, the diagnosis of PHP is elusive during infancy because PHP is usually diagnosed with hypocalcemia-induced symptoms, which develop later in childhood when calcium requirements increase. A 1-month-old girl was referred to our clinic for elevated thyroid-stimulating hormone (TSH) levels on newborn screening. When measured 1 month after levothyroxine treatment, her TSH level normalized. At 4-months-old, multiple hard nodules were noted on her trunk. A punch skin biopsy revealed osteoma cutis associated with Albright's hereditary osteodystrophy, a major characteristic of PHP. We performed targeted sanger sequencing of the gene and detected a heterozygous variant c.150dupA (p.Ser51Ilefs*3) in both the proband and her mother, causing frameshift and premature termination mutations. The patient was diagnosed with PHP Ia when she had normal calcium, phosphorous, and PTH levels. We report the early diagnosis of PHP Ia without hypocalcemia. It emphasizes the importance of meticulous physical examination in patients with congenital hypothyroidism.

Citing Articles

Complete Pseudo-Anodontia in an Adult Woman with Pseudo-Hypoparathyroidism Type 1a: A New Additional Nonclassical Feature?.

Sciacchitano S, De Francesco G, Piane M, Savio C, De Vitis C, Petrucci S Diagnostics (Basel). 2022; 12(12).

PMID: 36553004 PMC: 9777483. DOI: 10.3390/diagnostics12122997.

References
1.
Lee Y, Kim H, Kim H, Lee J, Choi J, Bae E . Identification of a novel mutation in a patient with pseudohypoparathyroidism type Ia. Korean J Pediatr. 2014; 57(5):240-4. PMC: 4102687. DOI: 10.3345/kjp.2014.57.5.240. View

2.
Sano S, Nakamura A, Matsubara K, Nagasaki K, Fukami M, Kagami M . (Epi)genotype-Phenotype Analysis in 69 Japanese Patients With Pseudohypoparathyroidism Type I. J Endocr Soc. 2018; 2(1):9-23. PMC: 5779104. DOI: 10.1210/js.2017-00293. View

3.
Picard C, Decrequy A, Guenet D, Bursztejn A, Toledano D, Richard N . Diagnosis and management of congenital hypothyroidism associated with pseudohypoparathyroidism. Horm Res Paediatr. 2015; 83(2):111-7. DOI: 10.1159/000369492. View

4.
Mantovani G, Ballare E, Giammona E, Beck-Peccoz P, Spada A . The gsalpha gene: predominant maternal origin of transcription in human thyroid gland and gonads. J Clin Endocrinol Metab. 2002; 87(10):4736-40. DOI: 10.1210/jc.2002-020183. View

5.
Mantovani G, Bastepe M, Monk D, de Sanctis L, Thiele S, Ahmed S . Recommendations for Diagnosis and Treatment of Pseudohypoparathyroidism and Related Disorders: An Updated Practical Tool for Physicians and Patients. Horm Res Paediatr. 2020; 93(3):182-196. PMC: 8140671. DOI: 10.1159/000508985. View